Years of cooperation within one group
Although the names were different, Pure Clinical and MDR Regulator have always been part of the same group and worked in close alignment. Many of our areas of activity already overlapped — from regulatory consulting to certification and clinical trials. The merger is therefore a natural next step in the evolution of our cooperation.
A stronger, integrated organization
This step is the culmination of months of preparation aimed at creating one strong, integrated organization. The regulatory expertise of MDR Regulator is now a fully embedded area within Pure Clinical, further broadening our comprehensive portfolio of services. For our clients and partners, this means smoother cooperation, faster processes, and access to a wider range of competencies — all within one structure.
Voices from the management board
– This merger is not only a change of name. It is a strategic decision to provide our partners with even broader support and a more unified structure — said Adam Sobantka, Member of the Management Board of Pure Clinical.
– We are convinced that the integration of our competencies will allow us to operate more effectively on both European and global markets. For our clients, it means one thing above all: greater value — added Katarzyna Wesołowska, Member of the Management Board of Pure Clinical.
Our mission remains unchanged — to facilitate and accelerate the safe and compliant introduction of innovative medical technologies to the market — but today, the possibilities are greater than ever.